Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026

At ASCO 2026, Lunit will present precision patient stratification and biomarker-driven oncology research through AI-powered HER2/IHC biomarker quantification and spatial tumor microenvironment analysis. SEOUL, South Korea, May 21, 2026 /PRNewswire/ -- Lunit, a leading provider of AI for...